| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.22 | 0.5 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |